Management of Septic Shock on Norepinephrine (Levophed) Drip
Norepinephrine is the first-choice vasopressor for septic shock, targeting a mean arterial pressure (MAP) of 65 mmHg, and should be initiated early—potentially before completing full fluid resuscitation—to minimize hypotension duration and reduce excessive fluid administration 1.
Initial Resuscitation and Vasopressor Initiation
Fluid Resuscitation
- Administer 30 mL/kg of crystalloids as initial fluid resuscitation 1
- Use either balanced crystalloids or normal saline 1
- Consider albumin supplementation when substantial crystalloid volumes are required 1
- Do not delay norepinephrine waiting for fluid resuscitation to complete—start vasopressors early when MAP remains inadequate despite initial fluids 2, 3
Starting Norepinephrine
Preparation and Administration:
- Dilute 4 mg (4 mL vial) in 1,000 mL of 5% dextrose solution (final concentration: 4 mcg/mL) 4
- Never use saline alone as diluent—dextrose-containing solutions prevent oxidation and potency loss 4
- Administer via large central or antecubital vein using a secure IV catheter 4
- Avoid leg veins, especially in elderly patients or those with peripheral vascular disease, due to gangrene risk 4
Dosing:
- Initial dose: 8-12 mcg/min (2-3 mL/min of standard dilution) 4
- Maintenance dose: 2-4 mcg/min (0.5-1 mL/min) 4
- Titrate to achieve MAP ≥65 mmHg 1
- In previously hypertensive patients, target MAP no higher than 40 mmHg below baseline systolic pressure 4
Monitoring and Titration
Essential Monitoring
- Blood pressure every 2 minutes during initiation until target achieved, then every 5 minutes 4
- Monitor infusion site continuously for extravasation—blanching indicates tissue ischemia risk 4
- Use central venous pressure monitoring to detect occult hypovolemia 4
- Never leave patient unattended while receiving norepinephrine 4
Perfusion Assessment
Beyond MAP targets, assess tissue perfusion using:
- Capillary refill time
- Lactate clearance
- Urine output
- Mental status
- Skin mottling
Recent evidence suggests perfusion-guided titration may be superior to rigid MAP targets alone 5, 6.
Escalation Strategy When Norepinephrine Alone Is Insufficient
Add Vasopressin
When norepinephrine requirements are moderate (typically 0.25-0.5 mcg/kg/min), add vasopressin 0.03 units/min rather than continuing to escalate norepinephrine 1, 7. This approach:
- Reduces catecholamine exposure and associated complications (arrhythmias, ischemia)
- Decreases risk of atrial fibrillation
- May provide renal protection 6, 7
- Do not use vasopressin as sole initial vasopressor 1
- Do not exceed 0.03-0.04 units/min except as salvage therapy 1
Add Epinephrine
If additional vasopressor support is needed beyond norepinephrine plus vasopressin, add epinephrine (or substitute for norepinephrine) 1. This is particularly useful when cardiac dysfunction coexists.
Consider Dopamine Only in Specific Cases
Use dopamine as alternative to norepinephrine only in highly selected patients with:
- Low risk of tachyarrhythmias
- Absolute or relative bradycardia 1
Never use low-dose dopamine for renal protection—this is explicitly not recommended 1.
Adjunctive Therapies
Corticosteroids
Add hydrocortisone (with or without fludrocortisone) in refractory shock to improve vasopressor responsiveness and potentially reduce mortality 8, 6.
Inotropic Support
If evidence of persistent hypoperfusion despite adequate MAP and filling pressures suggests cardiac dysfunction, add dobutamine or consider switching to epinephrine 1, 8.
High-Dose Norepinephrine Considerations
- Doses as high as 68 mg/day (17 vials) may occasionally be necessary 4
- Always suspect and correct occult hypovolemia before attributing hypotension solely to vasodilatory shock 4
- At high doses, strongly consider adding non-adrenergic vasopressors (vasopressin, angiotensin II) rather than continuing norepinephrine escalation 6, 7
Critical Safety Considerations
Extravasation Prevention
- Check infusion site frequently for free flow 4
- Blanching along vein course indicates vasa vasorum constriction—consider changing site 4
- If extravasation occurs, local necrosis may develop due to intense vasoconstriction 4
Drug Interactions
- Contraindicated with cyclopropane or halothane anesthesia—risk of ventricular arrhythmias 4
- Use extreme caution with MAO inhibitors or tricyclic antidepressants—severe prolonged hypertension may result 4
- Avoid in profound hypoxia or hypercarbia—increased arrhythmia risk 4
Avoid Hypertension
- Excessive dosing can cause dangerously elevated blood pressure 4
- Headache may signal hypertensive overdose 4
Weaning Strategy
- Continue infusion until adequate blood pressure and tissue perfusion are maintained without support 4
- Reduce gradually—avoid abrupt withdrawal 4
- Treatment duration varies widely; some patients require up to 6 days 4
Key Pitfalls to Avoid
- Delaying vasopressor initiation while pursuing aggressive fluid resuscitation—this increases fluid overload risk without improving outcomes 2, 3
- Using saline as sole diluent—causes drug degradation 4
- Infusing into leg veins in elderly or vascular disease patients—gangrene risk 4
- Escalating norepinephrine indefinitely without adding non-adrenergic vasopressors—increases catecholamine toxicity 6, 7
- Leaving patient unmonitored—rapid hemodynamic changes and extravasation require constant vigilance 4
- Using low-dose dopamine for renal protection—ineffective and not recommended 1